- Profile
- Personal Information
- Publications
Experts in Medicine
Ian Weeks Dr Steve Riley Simon Jones Michael Owen P S N Bhatt Dr Richard Adams Dhananjay Patel Megha G Pandya Lai Liangxue Hetal D Vyas Maxim Shyshkin Dr. Md. Ibrahim Khalil Mark Weatherall MOHD. SAJID KHAN Newton F Adkinson Alison G Abraham David B Abrams Patricia Priest Peter C Agre Julian Crane View MoreAlvin Shih
Chief Executive Officer
Biopharmaceutical
Roivant Sciences
Switzerland
Alvin Shih has served as the Chief Executive Officer of Enzyvant since November 2016. Prior to joining Enzyvant, Dr. Shih was the Chief Operating Officer for Rare Diseases at Pfizer, and the global head of R&D at Retrophin. Before joining biopharma, he was a healthcare consultant at LEK Consulting and McKinsey & Company. Dr. Shih holds an M.D. from the University of Alabama, an M.B.A. from Northwestern University, and completed his training in internal medicine at the Massachusetts General Hospital.
Biotechnology and Internal Medicine